Human Apolipoprotein-B-48 ELISA KIT(AKHB48)

Original reports
#Detection of apolipoprotein B-48 and B-100 carrying particles in lipoprotein fractions extracted from human aortic atherosclerotic plaques in sudden cardiac death cases.
Nakano, T., Nakajima, K., Niimi, M., Fujita, M.Q., Nakajima, Y., Takeichi, S, Kinoshita, M., Matsushima, T., Teramoto, T., and Tanaka, A.
Clinica Chimica Acta 390, 38-43, 2008.

#ApoB-100 carrying lipoprotein, but not apoB-48, is the major subset of proatherogenic remnant-like lipoprotein particles detected in plasma of sudden cardiac death cases.
Nakajima, K., Nakajima, Y., Takeichi, S., and Fijita, M.Q.
Atherosclerosis 194, 473-482, 2007.

# Determination of apolipoprotein B-48 in serum by a sandwich ELISA
Kinoshita, M., Kojima, M., Matsushima, T., and Teramoto, T.
Clinica Chimaca Acta, 351, 115-120, 2005.

# Decreased lipoprotein lipase activity and increased postprandial concentrations of triglyceride-rich lipoproteins in offspring of elderly survivors of myocardial infarction.
Lakhal, S., Borvik, T., Nordoy, A., and Hansen, J.B.
Nutrition, Metabolism and Cardiovascular Diseases (Epub ahead of print), 2008

#Effects of Intensive Atorvastatin,Rosuvastatin Treatment on Apolipoprotein
B-48 and Remnant Lipoprotein Cholesterol Levels Seiko Otokozawa,Masumi Ai,Thomas Van Himbergen,Bela F.Asztalos,Akira Tanaka,
Evan A.Stein,Peter H.Jones and Ernst J.Schaefer
Atheroscleroisis,In Press,Accepted Manuscript,Available online 12 November 2008

# Omega 3 fatty acids induce a markerd reduction of
apolipoprotein B48 when added to fluvastatin in
patients with type 2 diabetes and mixed hyperlipidemia
Cardiovasc Diabetol,8;8:1,2009

# Fasting and postprandial apolipoprotein B-48 levels in healthy,obese,and hyperlipidemic subjects
Otokozawa,S.,Ai,M., Diffenderfer,MR., Asztalos,BF.,Tanaka,A., Lamon-Fava,S., Schaefer,EJ.
Metabolism Clinical and Experimental .published online 10 July.2009

Presentations at scientific meetings
# Concentration of apolipoprotein B48 in fasting serum is an important marker of postprandial hyperlipidemia.
Hirota, D., Kinosita, M., Maeda, T., suda, T., Taki, M., Kusano, J., Takenaka, H., Yoshimura,
N., and Teramoto, T.
(Teikyo Univ. Sch. of Med. Int. Med.)
The 37th Japan Atherosclerosis Society Annual Meeting, 2005, English session ES-J8,Proceeding p.185

#Extended-Release Niacin Alters the Metabolism of Plasma
Apolipoprotein(Apo)A-I-and ApoB-Containing Lipoproteins.
Lamon-Fava S,Diffenderfer MR,Barrett PH,Buchsbaum A,Nyaku M,
Horvath KV,Asztalos BF,Otokozawa S,Ai M,Matthan NR,Lichtenstein
AH,Dolnikowski GG,Schaefer EJ.
Arterioscler Thromb Vasc Biol.2008 Jun 19.